Nine Masts Capital’s Amgen AMGN Stock Holding History

Nine Masts Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$68K	–	253
2017 Q4	$68K	Sell	200 -600	-75%	-$106K	0.01%	161
2017 Q3	$14K	Buy	800 +150	+23%	+$26.6K	﹤0.01%	149
2017 Q2	$89K	Buy	+650	New	+$106K	0.01%	140

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nine Masts Capital's AMGN Position: Q1 2018 in Review

Nine Masts Capital sold out of Amgen (AMGN) in Q1 2018, closing a stake of 9,098 shares — an estimated $1.58M sold.

Nine Masts Capital first reported a position in AMGN in Q3 2017 and held it in 2 quarters. The position peaked at $1.58M in Q4 2017. 1,750 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

Nine Masts Capital reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
Nine Masts Capital sold 9,098 Amgen shares in Q1 2018, an estimated $1.58M.
Nine Masts Capital first reported a position in Amgen in Q3 2017 and held it in 2 quarters.
Nine Masts Capital's Amgen position peaked at $1.58M in Q4 2017.
1,750 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Nine Masts Capital's 13F filing for Q1 2018, filed 14 May 2018.